Abstract
It has been previously shown that natural interferons(nIFNS) and-α and -γ delivered intralesionally(IL) to xenografts of human breast carcinomas in nude mice exerted a greater inhibitory effect than when they were administered systemically(1). Similarly, in patients with advanced malignant melanoma treated with IL injections of IFNα the local anti-tumoreffects were found to be significantly greater than the systemic effects(2). These observations suggest that the success of IFN therapy may depend, at least in part, on the ability to concentrate the IFN in the target tissue. Unfortunately, to achieve high local concentrations of IFN without causing undesirable side effects is difficult because IFNs are rapidly eliminated. Therefore, it would be desirable to devise means by which IFNs could be selectively delivered to tumors and retained in them for long periods of ti me. This might be possible by coupling IFNs to monoclonal antibodies(MoAbs) directed against antigens specifically expressed by the tumor cells.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
L. Ozzello, D.V. Habif, C.M. DeRosa, and K. Cantell, Treatment of human breast cancer xenografts using natural interferons α and-l<Math> injected singly or in combination, J. Interferon Res. 8:679(1988)
P. von Wussow, B. Berthold, F. Hartmann, and H. Deicher, Intralesional interferon-alpha therapy in advanced malignant melanoma, Cancer 61 :1071(1988).
S.S. Alkan, S. Miescher-Granger, D.G. Braun, and H.K. Hochkeppel, Anti vi ral and antiproliferative effects of interferons delivered via monoclonal antibodies, J.Interferon Res. 4:355(1984).
R. Tran, P. Horan Hand, J.W. Greiner, S. Pestka, and J. Schlom, Enhancement of surface antigen expression on human breast carcinoma cells by recombinant human interferons, J.Interferon Res. 8:75(1988).
J.W. Greiner, F. Guadagni, P. Noguchi, S. Pestka, D. Colcher, P.B. Fisher, and J. Schlom, Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo, Science 235:895(1987).
R.L. Ceriani, E.W. Blank, and J.A. Peterson, Experimental immunotherapy of human breast carcinomas implanted in nude mice with a mixture of monoclonal antibodies against human milk fat globule components, Cancer Res. 47:532(1987).
R.L. Ceriani, and E.W. Blank, Experimental therapy of human breast tumors with 131I_labeled monoclonal antibodies against the human milk fat globule, Cancer Res. 48:4664(1988).
K. Cantell, S. Hirvonen, H.-L. Kauppinen and G. Myllyla, Production of interferon in human leukocytes from normal donors with the use of Sendai virus, Methods Enzymol. 78:29(1981).
K. Cantell, S. Hirvonen, and H.-L. Kauppinen, Production and partial purification of human immune interferon, Methods Enzymol. 119:54(1986).
H.-L. Kauppinen, S. Hirvonen, and K. Cantell, Effect of purification procedures on the composition of human leukocyte interferon preparations, Methods Enzymol. 119:27(1986).
R.L. Ceriani, J.A. Peterson, J.Y. Lee, R. Moncada, and E.W. Blank, Characterization of cell surface antigens of human mammary epithelial cells with monoclonal antibodies prepared against human milk fat globule.Som. Cell Gen. 9:415(1983).
J.L. Dickerson, J.J. Kornuc, and D.C. Rees, Complex formation between Flavodoxin and Cytochrome c.J. Biol. Chem. 260:5175(1985).
L. Ozzello, D.V. Habif, C.M. DeRosa, and K. Cantell, Effects of intralesional injections of interferons α on xenografts of human mammary carcinomacells(BT 20 and MCF-7), J. Interferon Res. 8:208(1988).
S.S. Alkan, H. Towbin, and H.K. Hochkeppel, Enhanced antiproliferative action of interferon targeted by bispecific monoclonal antibodies, J. Interferon Res. 8:25(1988).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ozzello, L., DeRosal, C.M., Blank, E.W., Cantell, K., Habif, D.V., Ceriani, R.L. (1989). Potentiation of Anti-Tumor Efficacy Resulting from the Combined Administration of Interferon α and of an Anti-Breast Epithelial Monoclonal Antibody in the Treatment of Breasl Cancer Xenografts. In: Ceriani, R.L. (eds) Breast Cancer Immunodiagnosis and Immunotherapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1296-4_18
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1296-4_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1298-8
Online ISBN: 978-1-4757-1296-4
eBook Packages: Springer Book Archive